Medifast Inc banner

Medifast Inc
XMUN:MDF

Watchlist Manager
Medifast Inc Logo
Medifast Inc
XMUN:MDF
Watchlist
Price: 10.698 EUR -0.22%
Market Cap: €891m

Medifast Inc
Investor Relations

Medifast sells packaged weight-loss and healthy-eating products, mainly shakes, bars, soups, and other meal replacements. These products are built around its OPTAVIA program, which gives customers a structured plan for losing weight and maintaining habits through portion-controlled eating and coach support. The company’s main customers are adults trying to lose weight or manage their diet in a simple, guided way. Medifast makes money by selling its food products, usually through a network of independent OPTAVIA coaches who help enroll customers, explain the program, and keep them engaged. That makes the business part product company and part service model: the food is the core item being sold, but the coaching and community are a big reason people stick with the program. Medifast sits in the health and wellness aisle, but its model is different from a normal grocery brand because it sells a repeatable program rather than just individual snacks or supplements.

Show more
Loading...
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q1 2026
Call Date
May 4, 2026
AI Summary
Q1 2026

Revenue: First-quarter revenue was $76.0 million, down 34.3% year over year, but management highlighted that it was the first sequential quarterly revenue growth in 3 years.

Coach productivity: Average revenue per active earning coach rose 19.2% year over year to $5,432, with sequential growth of 16%, which management called a key early sign of a turnaround.

Guidance: Medifast reaffirmed full-year 2026 guidance and said it still expects profitability improvement to begin in Q4 2026 and continue into 2027.

Cost cuts: The company said its cost-structure changes are expected to generate more than $30 million in future savings and help support a return to profitability.

Strategy shift: Management said the company’s move from traditional weight loss to a broader metabolic health model is largely complete and the focus is now on execution and new product launches.

Leadership change: Dan Chard confirmed he will step down as CEO effective June 1 and remain Chairman, while praising Nick Johnson’s role in the strategy shift.

Key Financials
Revenue
$76.0 million
Active earning coaches
approximately 14,000
Revenue per active earning coach
$5,432
Gross profit
$51.8 million
Gross margin
68.1%
SG&A expense
$55.1 million
Loss from operations
$3.3 million
Net loss
$2.1 million
Loss per share
$0.19
Cash, cash equivalents and investments
$168.9 million
Working capital
$160.4 million
Future savings
more than $30 million
Earnings Call Recording
Other Earnings Calls

Management

Mr. Daniel R. Chard
Executive Chairman & CEO
No Bio Available
Mr. James P. Maloney CPA
Chief Financial Officer
No Bio Available
Mr. Anthony E. Tyree
Chief Business Operations Officer
No Bio Available
Mr. Jason L. Groves Esq.
Executive VP, General Counsel & Corporate Secretary
No Bio Available
Mr. Nicholas M. Johnson
Chief Field Operations Officer
No Bio Available
Mr. Jonathan Barrett MacKenzie
VP of Finance & Chief Accounting Officer
No Bio Available
Mr. Steven Zenker
Vice President of Investor Relations
No Bio Available
Ms. Claudia C. Greninger
Chief Human Resources Officer
No Bio Available

Contacts

Address
MARYLAND
Owings Mills
11445 Cronhill Dr
Contacts
+17327640619.0
www.medifast1.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett